Identification of a Gene Frequently Mutated in Prostate Tumors
J. K. Burmester(Marshfield Clinic), William J. Catàlona(Northwestern University), Sherry A. Salzman(Cancer Genetics (United States)), K. Q. Zhang(Marshfield Clinic), Brian K. Suarez(Washington University in St. Louis), Douglas J. Reding(Ascension), J. Vincent Thomalla(Marshfield Clinic), Roger E. Riepe(Marshfield Clinic)
Cited by 6
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996